|
 |
|
European BioPharmaceutical Review |
| |
|
European Biopharmaceutical Review (EBR) is a journal designed to fill a unique position in scientific publishing. Published quarterly, it provides a dedicated platform of communication and information for the European biopharmaceutical market across Europe, North America & the rest of the world.
With editorial consisting of in-depth articles, case studies, meeting and report reviews written by specialists with hands-on experience in the biopharmaceutical industry, traditional multi-national pharmaceutical companies, investment houses and industry-associated governmental, economic and societal bodies. Each quarterly edition examines topical areas of importance across the board of biopharmaceutical research and development, with regular feature sections on BioBusiness Development, Research and Innovation, BioDiscovery, BioManufacturing plus special focuses on geographic or therapeutic territories.
|
|
|
|
|
|
 |
Industry Events |
 |
Improving Solubility
21-23 June 2010, London, UK
Consequently, Pharma IQ’s 6th Annual Improving Solubility conference taking place in London on 22nd- 23rd June with pre-conference workshops on 21st June will explore the newest solubility enhancement technologies, and the best practice strategies of their implementation to ensure efficiency from discovery to preclinical development.
More info >> |
|
 |
News and Press Releases |
 |
Almac Doubles Capacity at North Carolina Facility
The Almac Group has completed a 67,000 square foot expansion to their North Carolina facility in Durham, which now houses both the Clinical Services and Diagnostics Divisions. Almac Clinical Services first began occupancy of the additional building on the campus in February 2008 and have since added a 30,000 square foot warehouse complete with two new loading docks. Staff from Almac Diagnostics’ nearby facility in Durham have relocated to the site and are engaged in research activity across a wide-range of projects.
More info >> |
|
|
